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Abstract
Objective To systematically investigate the literature for the
influence of sublingual nitroglycerin administration on coro-
nary diameter, the number of evaluable segments, image qual-
ity, heart rate and blood pressure, and diagnostic accuracy of
coronary computed tomography (CT) angiography.
Methods A systematic search was performed in PubMed,
EMBASE and Web of Science. The studies were evaluated
for the effect of sublingual nitroglycerin on coronary artery
diameter, evaluable segments, objective and subjective image
quality, systemic physiological effects and diagnostic accura-
cy. Due to the heterogeneous reporting of outcome measures,
a narrative synthesis was applied.
Results Of the 217 studies identified, nine met the inclusion
criteria: seven reported on the effect of nitroglycerin on coro-
nary artery diameter, six on evaluable segments, four on image
quality, five on systemic physiological effects and two on
diagnostic accuracy. Sublingual nitroglycerin administration
resulted in an improved evaluation of more coronary seg-
ments, in particular, in smaller coronary branches, better im-
age quality and improved diagnostic accuracy. Side effects
were mild and were alleviated without medical intervention.
Conclusion Sublingual nitroglycerin improves the coronary
diameter, the number of assessable segments, image quality
and diagnostic accuracy of coronary CT angiography without
major side effects or systemic physiological changes.
Key Points
• Sublingual nitroglycerin administration results in significant
coronary artery dilatation.
• Nitroglycerin increases the number of evaluable coronary
branches.
• Image quality is improved the most in smaller coronary
branches.
• Nitroglycerin increases the diagnostic accuracy of coronary
CT angiography.
• Most side effects are mild and do not require medical
intervention.
Keywords Nitroglycerin . Computed tomography .Coronary
CTangiography . Coronary vasodilation . Coronary artery
disease
Introduction
Coronary computed tomography angiography (CCTA) has
become a useful tool for the exclusion of significant coronary
artery disease (CAD) [1–3]. CT allows for image acquisition
with high spatial and temporal resolution. Nonetheless, it can
be challenging to visualize coronary branches with a small
diameter [4]. In clinical practice, nitroglycerin is applied for
rapid coronary vasodilation, without causing significant
changes in heart rate or blood pressure [5]. Nitroglycerin gen-
erates nitric oxide, which initiates smooth muscle relaxation
independent of endothelial function [6]. Nitroglycerin also
reduces the likelihood of coronary artery vasospasm.
Nitroglycerin is widely administered to alleviate angina
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pectoris and has a half-life of about 5 minutes [7, 8].
Sublingual spray is the preferred method of administration
since it is the most efficacious and is associated with fewer
side effects [9, 10]. In acute myocardial infarction, sublin-
gual nitroglycerin rapidly relieves pulmonary congestion
and decreases myocardial oxygen consumption, although
administration might result in a decline in cardiac output
[11]. Headache and dizziness are most frequently associ-
ated with the use of nitrates [9]. Headaches following the
use of sublingual nitroglycerin are fairly common, but are
generally short-lasting and self-limiting. Dizziness is typ-
ically the result of nitroglycerin-induced hypotension.
More serious side effects can occur in patients with di-
minished cardiac output/severe hypotension, in patients
with increased intracranial pressure or patients using
phosphodiesterase inhibitors [9, 12]. Feldman et al. [5]
demonstrated in invasive coronary angiography that small
doses of nitroglycerin result in significant coronary artery
and collateral dilatation, without significant changes in
heart rate and blood pressure. The administration of ni-
trates was recommended for conventional coronary angi-
ography by the American College of Cardiology/
American Heart Association (ACC/AHA) in 1999, be-
cause it allowed for reliable assessment of coronary ste-
nosis degree [13, 14]. Subsequently, sublingual nitroglyc-
erin has been routinely used to dilate coronary arteries in
CCTA examinations to optimize visualization of the cor-
onary artery lumen and thus improve stenosis assessment
[3, 15, 16].
Multiple studies evaluated the use of sublingual nitroglyc-
erin in CCTA, however the evidence has not been systemati-
cally reviewed. This systematic review intended to summarize
the current evidence on the effects of sublingual nitroglycerin
on coronary diameter, the number of evaluable segments, im-




To identify all potentially relevant studies, a systematic search
was performed using predefined criteria. PubMed, EMBASE
and Web of Science were searched to December 2014. The
databases were searched using the subject headings
Bsublingual nitroglycerin^ or Bnitroglycerin^ or Bnitrate^ or
Bnitric oxide donors^ and Bcomputed tomography^ or BCT^
or BCCTA^ and Bcoronary^ or Bcardiac^. No search restric-
tions were applied. A manual reference check of included
articles was performed to identify potential studies missed
by our search strategy.
Eligibility Criteria
Article eligibility was determined using predefined criteria.
Articles were included based on the following criteria: study
domain, patients with suspected or known CAD; index test,
CT; evaluation of premedication, nitroglycerin; study results,
coronary artery diameter, evaluable segments, objective and
subjective (e.g., Likert scale) image quality, systemic physio-
logical effects and diagnostic accuracy. When studies
stemmed from overlapping populations, the study with the
largest population was included. Animal studies and phantom
studies were excluded.
Data Extraction and Analysis
Data were extracted by two reviewers. CT hardware, study
design, number of patients, use of β-blockers, heart rate, ni-
troglycerin dose and time between scan were recorded and
summarized. Due to the heterogeneous reporting of outcome
measures for each study, a formal meta-analysis was not pos-
sible. We thus applied a narrative synthesis of the effect of
sublingual nitroglycerin on coronary artery diameter,
evaluable segments, objective and subjective image quality,
systemic physiological effects and diagnostic accuracy.
Results
Literature search and assessment
The initial search identified 217 papers after removal of du-
plicates (Fig. 1). After title/abstract screening, 27 studies
remained for full text assessment. Eighteen papers were ex-
cluded because they did not meet the predefined selection
criteria, yielding a total of nine studies.
Study characteristics
The study characteristics of the included studies are listed in
Table 1. Of these, seven reported on the effect of nitroglycerin
on coronary artery diameter, six on evaluable segments, four
on image quality, five on systemic physiological effects and
two on diagnostic accuracy.
Coronary artery diameter
Seven studies evaluated the effect of sublingual nitroglycerin
on coronary diameter on CCTA. Two studies used a random-
ized design [20, 23], one used intra-individual comparison
[17, 25], one used a matched design [22] and two used a
retrospective review of their database [18, 24]. All studies
demonstrated an overall increase in diameter with the use of
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nitroglycerin, ranging from 8 to 30 % (Table 2). Klass et al.
[22] showed that the relative vessel diameter increase is larger
in distal segments compared to proximal segments. Okada
et al. [25] and Sato et al. [23] confirmed this observation for
peripheral segments. Kang et al. [18] found a relative increase
in diameter in two patients who underwent CCTA with and
without administration of nitroglycerin.
Evaluable segments
Six CCTA studies evaluated the effect of sublingual nitroglyc-
erin on the number of evaluable segments/branches [18–20,
23–25]. All studies showed an improvement in the number of
evaluable segments in the nitroglycerin group. Okada et al.
[25] observed a non-significant increase in their intra-
individual comparison in 52 patients. The effect was particu-
larly profound when only comparing the number of side
branches, as was performed by Decramer et al. [20]. Lee
et al. [24] found a significant improvement in the visibility
of second order branches of the left anterior descending
(LAD) artery and the right coronary artery (RCA). Chun
et al. [19] showed that the application of nitroglycerin resulted
in significantly more evaluable distal segments.
Image quality
Two studies found that the administration of sublingual nitro-
glycerin resulted in significantly better subjective image qual-
ity, especially for the posterior descending artery [22, 24].
Decramer et al. [20] did not observe an effect of nitroglycerin
on objective measures such as signal-to-noise and contrast-to-
noise ratio, nor did they observe a difference in the number of
scans with substantial artefacts with the use of sublingual ni-
troglycerin. Okada et al. [25] did not find a significant differ-
ence in subjective image quality. Two studies observed signif-
icantly higher intraluminal attenuation in the nitroglycerin
group for the more peripheral vessels [22, 25].
Systemic physiological effects
Three studies observed no significant changes in blood pres-
sure and/or heart rate [19–21]. Twomore extensive studies did
observe a significant change in heart rate, though heart rate
variability tended to be lower in the group that received nitro-
glycerin [23, 25]. Okado et al. also observed a notable de-
crease in systolic (10.6 %) and diastolic (9.1 %) blood pres-
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Fig. 1 Flow chart. Search
performed on December 23, 2014
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hemodynamics after 4 minutes. Only a few studies reported on
side effects; all were mild (e.g., headache or dizziness) and
were alleviated without medical intervention [19, 20, 23, 24].
Diagnostic accuracy
The effect of sublingual nitroglycerin on diagnostic perfor-
mance was evaluated in two studies using 16-detector row
CT [18, 19]. Sensitivity and specificity were evaluated for a
≥50 % stenosis degree. Chun et al. [19] reported a sensitivity
of 97.0 % for patient-based evaluation with a specificity of
84.6 % for the nitroglycerin group compared to 90.0 % and
70.0 %, respectively, for the control group. Diagnostic accu-
racies for proximal, mid, and distal segments were all higher
in the patients who received sublingual nitroglycerin. Overall
sensitivity for segment-based evaluation was 83.0 % with a
specificity of 97.8 % for the nitroglycerin group compared to
63.6 % and 94.8 %, respectively, for the control group. Kang
et al. [18] determined the diagnostic accuracy in a subset of 42
patients who underwent invasive coronary angiography. On a
segment basis, they found a comparable diagnostic accuracy
of 79.5 % for the nitroglycerin group and 84.1 % for the
control group. The diagnostic accuracy for finding any athero-
sclerosis was higher in the nitroglycerin group (85.8 % vs.
80.1 %).
Discussion
This systematic review provides an overview of the current
evidence on the effect of sublingual nitroglycerin. We found
that one to two pumps of sublingual nitroglycerin (0.4-0.8mg)
increased coronary diameter, the number of assessable coro-
nary artery segments, image quality and diagnostic accuracy
of CCTA. The administration of nitroglycerin seems to be
especially beneficial in smaller coronary branches. We ob-
served among the included studies an increase in the number
of evaluable segments as well as an increase in subjective and
objective image quality in smaller coronary branches. The
spatial resolution of CT may not be sufficiently high to visu-
alize the smallest coronary branches; nevertheless nitroglyc-
erin administration is able to increase the number of evaluable
segments.
Sato et al. [23] recorded heart rate and blood pressure every
minute during image acquisition and observed significant
changes in systemic hemodynamics after 4 minutes.
However, only one scan acquisition was acquired and, thus,
evaluation of maximal coronary dilatation was not feasible.
Pepe et al. [26] observed a maximal vasodilator response be-
tween 4 and 5 minutes after nitroglycerin administration using
magnetic resonance imaging (MRI) for visualization of the
coronary artery lumen. Also, they noted among their subjects
substantial heterogeneity in the time point of maximal
coronary dilatation. On the basis of these studies, the optimal
starting time for image acquisition is probably between 3 and
4 minutes after sublingual administration of nitroglycerin.
A point of concern is that the administration of nitroglyc-
erin could result in overestimation of the stenosis degree [27].
Conti et al. [28] showed in 47 patients (119 coronary artery
stenoses) undergoing conventional angiography that the use
of sublingual nitroglycerin results in a significant increase in
percentual stenosis (8 % mean) and that the more narrowed
stenoses were less likely to dilate. This finding could be ex-
plained by a decrease in vascular reactivity to nitroglycerin in
diseased vessels, especially in atherosclerotic segments with
circumferential disease [29]. Another point of concern with
the administration of nitroglycerin is that it can result in a
decrease in blood pressure or reflex tachycardia [9, 30].
Reflex tachycardia, although rare, could result in more motion
artefacts on CCTA [30]. Only Decramer et al. [20] evaluated
the effect of nitroglycerin on the presence of substantial arte-
facts and did not observe significant differences.
The applicability of nitroglycerin in certain subgroups is of
interest. Females have smaller coronary arteries compared to
males after controlling for differences in body size [31].
Moreover, oestrogen affects vascular tone through production
of nitric oxide by the endothelium [32, 33]. However, none of
the included studies investigated the effect of nitroglycerin in
women compared to men. Another potentially challenging
population are hypertensive patients, although in a small study
using invasive angiography, no significant change in the lu-
men area was observed between normotensive and hyperten-
sive patients after administration of sublingual nitroglycerin
[34].
An interesting new field is the effect of nitroglycerin on the
diagnostic accuracy of fractional flow reserve CT (FFRCT).
Advances in computational fluid dynamics allow for calcula-
tion of hemodynamic significance of coronary stenoses in
CCTA examinations, which is based on an anatomic model
of the coronaries generated from CCTA data [35]. In the
DeFACTO study [36], the effect of sublingual nitroglycerin
on diagnostic accuracy of FFRCT was evaluated.
Administration of nitroglycerin was linked to improved spec-
ificity of FFRCT (55.2 % vs. 65.0 %). Improvement in the
diagnostic accuracy of FFRCTwas most profound when nitro-
glycerin was given 30 minutes or less before the CCTA ex-
amination (67.5 % vs. 78.6 %), which underscores the impor-
tance of early image acquisition after administration of sub-
lingual nitroglycerin.
A limitation of this systematic review was that many stud-
ies used 16-slice CT, which is considered suboptimal for cor-
onary imaging due to limited temporal resolution compared to
current CT scanners. Second, only two studies evaluated the
effect of nitroglycerin using an intra-individual comparison.
Third, the time between sublingual nitroglycerin administra-
tion and scan acquisition was not listed in all of the included
3540 Eur Radiol (2015) 25:3536–3542
studies. Finally, we were not able to meta-analyze our findings
due to the heterogeneous reporting of outcome measures.
In conclusion, despite its widespread use in clinical prac-
tice, only a few comprehensive studies evaluating the effect of
nitroglycerin in coronary CCTA have been published. Our
systematic review of the available evidence on the use of
sublingual nitroglycerin in CCTA suggests that nitroglycerin
improves coronary diameter, the number of assessable seg-
ments, image quality, and diagnostic accuracy, although only
a few studies met the inclusion criteria. Only mild systemic
physiological changes which may impact image quality can
be expected if scan acquisition is performed within 4 minutes
after nitroglycerin administration. However, the vasodilatory
effects of nitroglycerin are reduced in atherosclerotic coronary
segments. More studies are needed to assess the effect of ni-
troglycerin on stenosis assessment and FFRCT measurements,
especially when CCTA is performed on current generation
scanners.
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